CenterPoint Energy (CNP) raised its 2026 earnings guidance to $1.90 to $1.92 on October 27, 2026 and opened 2027 at $2.07 to $2.09. The shares, at $42.295, are up about 11.9% over the past month. For the next two to six weeks the balance of evidence leans positive, with high conviction (3 of 4 points). The daily trend runs with the weekly uptrend, and CNP leads both the S&P 500 and XLU. The $42.41 level is the next test.
Why it matters
The October 27 report was a clean beat. Non-GAAP earnings were $0.53 a share against a consensus of $0.49, while revenue of $2.12 billion matched expectations, Investing.com reported. The more important news was forward-looking. Management introduced 2027 guidance of $2.07 to $2.09, which implies about 9% growth, and lifted its ten-year capital plan by $4 billion to $70.7 billion through 2035, The Motley Fool noted. For a regulated utility, a bigger capital plan is the engine of earnings growth. The guidance raise shows that engine is running ahead of plan.
The data here does not isolate the stock's reaction on the day of the report. What is visible is a month-long advance of 11.9% that carried straight through it. The stock set a recent peak close of $42.65 on November 2 and sits 0.8% below it today. Today's dip came on volume 44.2% below the 20-day average, so it looks like a quiet pause, not a sell-off. The last five days split as follows: CNP gained 0.77%, the S&P 500 fell 2.03% and XLU rose 1.25%. The market gave CNP no lift. The sector did most of the work, and the stock trailed its sector by about half a point. Over 50 days the picture is different. CNP leads the S&P 500 by 9.6 points and XLU by 3.8, so the stock has been outperforming for more than a week.
The public argument is lopsided. On the positive side, Investing.com reported that Scotiabank put CenterPoint among its five top regulated utility picks ahead of earnings, citing data center growth. Bloomberg reported that Bank of America hired a senior power banker to lead utilities investment banking, a sign that AI-related energy dealmaking is drawing capital. The feed holds no published bearish case on CNP. The skeptical argument comes from the tape: an RSI of 71, a price just under resistance, and thin volume on the latest move.
Valuation leaves moderate room. The 19 analysts rate the stock a consensus buy, with a mean price target of $44.24, which puts the shares 4.4% below it. Targets run from $39 to $50, so the spread is wide. The low end sits below today's price and just under the 50-day average, while the high end is $50. The mean target coincides with the first swing-zone level above the price, which makes $44.24 a meaningful number on both the chart and the analyst sheet.
What the evidence says
The long-term thesis is intact. Price is above both its 10-week and 40-week averages, so the weekly trend is up. The stock is in a recovery phase, 15.6% above its 52-week low of $36.62 and 6.0% below its high of $45.04. The six-month change is still slightly negative at 2.4%, and over 200 days CNP trails the S&P 500 by 2.0 points. The advance is therefore recent, and it has only just carried the stock back above its 200-day average of $41.6.
For the next two to six weeks the balance of evidence leans positive, and conviction is high at 3 of 4 points. The daily trend runs with the weekly uptrend, and CNP leads the S&P 500 over 50 days by 9.6% and XLU by 3.8%. The strongest case against this reading is stretched momentum. An RSI of 71 is overbought. Volume is running 44.2% below its 20-day average, so the latest push has not drawn heavy participation. Over five days the stock lagged its sector by half a point. Those points are why conviction stops at 3 of 4. They argue for a pause or a pullback, but they do not break the trend, since price remains above the 200-day average and the weekly averages.
Levels that matter
The structure holds above $41.6, the 200-day average. A first crack would come below that line, and the trend ends below $41.4, a swing-zone support that sits just beneath it. Further down are $40.14, the 50-day average at $39.28, and $38.58. The two levels at $41.6 and $41.4 are close together, so the zone is tight, and the weekly close is what separates a dip from a break.
The breakout level is $42.41, a swing-zone resistance just above the $42.295 price. A daily close above it on volume above the 20-day average would be the first sign that buyers are back. From there the first target is $44.24, a 1.8 to 1 reward against a stop at $41.41, which is the 200-day average minus a quarter of the 14-day ATR. The second target is $45.24, at 2.8 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk. Only a target beyond $45.24 would do that, and the next mapped level above it is the round $50.
What would change the picture
A weekly close below $41.4 would change the picture, because it would end the structure that has held since the advance began. The non-price fact most likely to do it is a cut to the 2027 earnings guidance of $2.07 to $2.09, or to the $70.7 billion capital plan that supports it. Either would undercut the growth story behind the 11.9% monthly gain.
What to watch
- Earnings: the latest report was October 27, 2026, and the data shows no later date yet. The number that matters is the 2027 guidance range of $2.07 to $2.09, along with progress toward the 2026 range of $1.90 to $1.92.
- Sector: XLU rose 8.9% over the past month and has driven most of CNP's recent gains. A reversal in utilities would hit the stock before any company news. Deal activity in power and AI-related energy, as the Bank of America hire suggests, is part of the same backdrop.
- Valuation: at $42.295 the stock is 4.4% below the $44.24 mean target, with analyst targets spanning $39 to $50.